Discovery of Potent, Selective, and Orally Available IRE1 alpha Inhibitors
Inositol-requiring enzyme 1α (IRE1α) is a sensor protein that plays a key role in multiple myeloma (MM) and is a...
Continue Reading
Inositol-requiring enzyme 1α (IRE1α) is a sensor protein that plays a key role in multiple myeloma (MM) and is a...
Continue Reading
SARS-CoV-2 antivirals which have been clinically approved or are in late-stage development are directed against either the RNA-dependent RNA polymerase...
Continue Reading
Glucagon‐like peptide‐1 (GLP-1) receptor agonists have emerged as promising therapeutic options for addressing type‐2 diabetes, obesity, and related conditions. However,...
Continue Reading
High throughput experimentation (HTE) is frequently employed to identify reaction conditions for challenging transformations, giving access to a diverse array...
Continue Reading
Despite the availability of modern screening technologies, identification and optimization of hits against poorly druggable targets remains a significant challenge...
Continue Reading
Fragment-based drug discovery (FBDD) is one of the most well-developed approaches for projects starting from small, low-affinity compounds. At the...
Continue Reading
The recent publication in the journal Organic Letters, ‘DNA-Compatible Cyclization Reaction to Access 1,3,4-Oxadiazoles & 1,2,4-Triazoles‘ by our WuXi Biology...
Continue Reading
The contribution of the X-ray crystallography team from our WuXi AppTec site in Germany was acknowledged in a recent study...
Continue Reading
Introduction: Targeted Protein Degradation (TPD) has emerged as a promising therapeutic modality due to its potential to develop therapeutics for...
Continue Reading